Hainv Gao

TL;DR: This Article contains typographical errors in Table 2 where ‘Week 2 (N = 32)’ was incorrectly given as ‘week (n’=‬2’.

TL;DR: Cross species poultry-to-person transmission of this new reassortant H7N9 virus is associated with severe pneumonia and multiorgan dysfunction in human beings and monitoring of the viral evolution and further study of disease pathogenesis will improve disease management, epidemic control, and pandemic preparedness.

TL;DR: The presence of a coexisting medical condition was the only independent risk factor for the acute respiratory distress syndrome (ARDS) during the evaluation period, and the novel H7N9 virus caused severe illness, including pneumonia and ARDS, with high rates of ICU admission and death.

TL;DR: The gut microbial signature of patients with COVID-19 was different from that of H1N1 patients and HC, suggesting the potential value of the gut microbiota as a diagnostic biomarker and therapeutic target for CO VID-19, but further validation is needed.

TL;DR: It is suggested that MSCs significantly improve the survival rate of H7N9-induced ARDS and provide a theoretical basis for the treatment of H6N9 and the corona virus disease 2019 (COVID-19) in both preclinical research and clinical studies.